Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)
NCT00002031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the effect of application of Dinitrochlorobenzene (DNCB) on the number, morphology, and antigen expression of epidermal Langerhans cells in AIDS and AIDS related complex (ARC) patients.
Conditions
- HIV Infections
Interventions
- DRUG
-
Dinitrochlorobenzene
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets
NCT02993237 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
NCT00002013 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001011 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of DTC in Patients With AIDS and AIDS Related Complex
NCT00002069 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure
NCT02232581 ·Status: COMPLETED ·Phase: PHASE2
-
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients
NCT03164447 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease
NCT00000729 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nystatin in HIV-Infected Patients
NCT00002313 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)
NCT00000659 ·Status: TERMINATED ·Phase: PHASE2
-
A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
NCT00000704 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
NCT00002311 ·Status: COMPLETED ·Phase: PHASE1
-
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
NCT05555862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000725 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
NCT00659971 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
NCT00002058 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals
NCT03571204 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex
NCT00000710 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)
NCT00002279 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002338 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
NCT00389311 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)
NCT00001998 ·Status: COMPLETED ·Phase: NA
-
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
NCT00002057 ·Status: COMPLETED ·Phase: NA